InDevR’s access to FDA’s front-line monoclonal antibodies ensures responsive potency assay for influenza vaccines BOULDER, Colo.–InDevR, a Boulder-based progressive analytical technology and life science instrumentation company, today announced that it has entered into an agreement to license monoclonal antibodies from the US Food and Drug Administration (FDA). This agreement enables InDevR to consistently manufacture and […]
Abbkine Scientific Company Limited recently announced the release of a new product called Anti-β-Actin Mouse Monoclonal Antibody (1C7), a synthetic peptide hosted by the mouse. The liquid solution, released singularly for research use and not for human or clinical use, is another giant stride from one of the world’s leading research and scientific company. ACTB is […]
Meridian an Exclusive Distributor in China, Hong Kong, Taiwan and Macau TORONTO, ONTARIO — Microbix Biosystems Inc. (TSX:MBX) (“Microbix”), an innovator of biological products and technologies, today announced it has signed a distribution agreement (the “Agreement”) with Meridian Life Science, Inc. (“Meridian”) a wholly owned company of Meridian Bioscience, Inc. (NASDAQ:VIVO) a fully integrated global […]
Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its GeneSys software has been upgraded to include an icon of pre-set optimised “stain-free” protein gel imaging conditions. This simple to use software, available to download free of charge to existing users of specified Syngene imaging systems, will save set-up time […]
Alameda, CA – Singulex, Inc. today announced that it has entered into a strategic collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) focused on the development of companion diagnostics. Through the collaboration, QIAGEN will have access to Singulex’s Single Molecule Counting immunodiagnostic platform, adding additional immunoassay capabilities to QIAGEN’s existing molecular testing services […]
Cambridge, UK: Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the launch of the Conjugate Check&Go! Kit, the company’s first lateral flow product specific to antibody labeling. The new kit allows scientists to confirm, in one easy step, whether an antibody has been successfully conjugated before moving on to more extensive […]
– Expected Full Year 2016 Revenue Growth of 36% to 39% Year over Year – SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year ended December 31, 2016. Financial Highlights: Total revenue for 2016 expected to be in […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the […]
Pall ForteBio acquires the Pioneer SPR Platform from SensiQ Technologies, expanding its portfolio of BLI-based biomolecular characterization instruments to include SPR-based small molecule fragment screening and more detailed biologics characterization. Freemont, CA Pall ForteBio, the developer and provider of industry-leading label-free biosensor technology platform, today announced that they will acquire the assets related to SensiQ’s […]
WASHINGTON, D.C. MINNEAPOLIS, MN – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) today announced that it has partnered with the Bio-Techne Corporation, a manufacturer of biotechnology products for life science research and diagnostics. The partnership was established to evaluate the suitability of a soluble form of receptor for advanced glycation end products (sRAGE) as a predictive biomarker […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
